Clinical and pharmaceutical analysis features of use of oral hypoglycemic agents

In order to evaluate the rationality of the use of oral hypoglycemic agents retrospectively analyzed 106 medical histories of patients with diabetes mellitus type 2 aged 42 to 75 years. Irrational application of preparations found in more than two-thirds of patients (with severe cardiovascular disease; with drugs affecting glucose-lowering activity, the risk of lactic acidosis, etc.). Improving the quality of treatment requires careful adjustment of pharmacotherapy, which justifies the need for participation in the process of clinical pharmacist.